Publicis Groupe Half-Year Financial Statement Liquidity Contract

PARIS--(BUSINESS WIRE)-- Regulatory News:

Under the liquidity contract of Publicis Groupe (Paris: PUB) [Euronext Paris: FR0000130577, CAC40] with Kepler Capital Markets SA, the following means were attributable to the liquidity contract at June 30, 2015:

- 270,000 Publicis Groupe shares- €4,773,294

It is reminded that at December 31, 2014, the following means appeared in the contract:

- 22,830 Publicis Groupe shares- €15,309,624.39

About Publicis GroupePublicis Groupe [Euronext Paris FR0000130577, CAC 40] is a global leader in marketing, communication, and business transformation. In a world marked by increased convergence and consumer empowerment, Publicis Groupe offers a full range of services and skills: digital, technology & consulting with Publicis.Sapient (SapientNitro, Sapient Global Markets, Sapient Government Services, Razorfish Global, DigitasLBi, Rosetta) - the world’s largest most forward-thinking digitally centered platform focused exclusively on digital transformation in an always-on world - as well as creative networks such as BBH, Leo Burnett, Publicis Worldwide, Saatchi & Saatchi, public affairs, corporate communications and events with MSLGROUP, ad tech solutions with VivaKi, media strategy, planning and buying through Starcom MediaVest Group and ZenithOptimedia, healthcare communications, with Publicis Healthcare Communications Group (PHCG), and finally, brand asset production with Prodigious. Present in 108 countries, the Groupe employs more than 76,000 professionals.www.publicisgroupe.com | Twitter: @PublicisGroupe | Facebook:www.facebook.com/publicisgroupe | LinkedIn: Publicis Groupe | http://www.youtube.com/user/PublicisGroupe | Viva la Difference !

View source version on businesswire.com: http://www.businesswire.com/news/home/20150703005106/en/

Publicis Groupe
Peggy Nahmany, + 33 (0)1 44 43 72 83
Corporate Communications
[email protected]
or
Jean-Michel Bonamy, + 33 (0)1 44 43 77 88
Investor Relations
[email protected]

Source: Publicis Groupe

You May Also Be Interested In

• EU approves Merck's Keytruda plus Padcev for bladder cancer
• Devon Announces Expiration and Final Results of its Private Exchange Offers and Consent Solicitations
• THCA Flower for Sale: BudPop Highlights Premium Lab-Tested Strains as Consumer Demand Grows in 2026